Oppenheimer Asset Management Inc. Agios Pharmaceuticals, Inc. Transaction History

Oppenheimer Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$32.4 - $49.58 $356 - $545	-11 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$42.73 - $76.53 $470 - $841	11 New	11 $1,000
Q4 2017 Feb 07, 2018	SELL	$52.12 - $72.33 $1,928 - $2,676	-37 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $2,030 - $2,483	37	37 $2,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.